An earlier study also showed a trend toward a decrease in RV end-systolic and end-diastolic areas with oral bosentan treatment without achieving statistical significance, 24) which is in agreement with the results of the current study.
← all excerpts
Beneficial and adverse effects of bosentan treatment in korean patients with pulmonary artery hypertension.
1
—
—